# The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants

> **NCT06200844** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Bharat Biotech International Limited** · enrollment: 5800 (estimated)

## Conditions studied

- Rotavirus Infection of Children

## Interventions

- **BIOLOGICAL:** ROTAVAC 5D
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06200844
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-07
- **Primary completion:** 2025-01-04
- **Final completion:** 2026-07
- **Target enrollment:** 5800 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200844, "The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06200844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*